caldip 10mg infusion - Nimodipine (10mg) medicine

Caldip 10mg Infusion (Nimodipine): Complete Medicine Guide

No reviews yet
🏭 Alfa Igra Inc 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 25, 2026
⚠️ Hepatotoxicity Risk 📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: Established for prevention of vasospasm after aneurysmal subarachnoid haemorrhage in specialist settings; limited for other uses.
Reviewed by
SaathiMed Expert Panel | Oct 25, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Severe dizziness or fainting
  • Chest pain or difficulty breathing
  • Very slow or irregular heartbeat
  • Sudden swelling of the face, lips, or throat
  • New weakness, numbness, or difficulty speaking
  • Severe headache with vomiting or visual changes
  • Unusual bruising or bleeding
  • Yellowing of the skin or eyes
  • Decreased urine output
  • Confusion or reduced level of consciousness

If experiencing severe symptoms, call emergency services immediately.

What is caldip 10mg infusion used for?

This medicine is an intravenous calcium channel blocker used mainly to prevent and treat cerebral vasospasm after a subarachnoid haemorrhage. It relaxes brain arteries, improves blood flow, and is given only in hospital under close monitoring because it can lower blood pressure.

  • Generic Name: Nimodipine
  • Manufacturer: Alfa Igra Inc
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 caldip 10mg infusion के बारे में (Hindi Summary)

उपयोग: यह दवा निमोडिपिन 10 मिलीग्राम का इंट्रावेनस इन्फ्यूजन है, जिसका उपयोग मुख्य रूप से सबअराक्नॉइड हैमरेज के बाद दिमाग की रक्त वाहिकाओं में होने वाली सिकुड़न (सेरेब्रल वैसोस्पाज्म) को रोकने और उसका इलाज करने के लिए किया जाता है। यह दवा दिमाग की धमनियों को आराम देकर रक्त का प्रवाह बेहतर बनाती है और दिमाग को होने वाले नुकसान का खतरा कम करती है। यह दवा सिर्फ अस्पताल में, डॉक्टर या नर्स की निगरानी में, इन्फ्यूजन पंप की मदद से दी जाती है। इसे घर पर खुद से नहीं लगाया जा सकता। इलाज के दौरान ब्लड प्रेशर और हृदय गति की लगातार निगरानी की जाती है, क्योंकि इससे ब्लड प्रेशर अचानक गिर सकता है।

साइड इफेक्ट्स: इस दवा के आम दुष्प्रभावों में ब्लड प्रेशर कम होना, सिरदर्द, जी मिचलाना, चेहरे पर गर्मी लगना और चक्कर आना शामिल हैं। कुछ मरीजों में दिल की धड़कन तेज या धीमी हो सकती है, या पैरों में सूजन आ सकती है। कभी-कभी खून में प्लेटलेट्स कम हो सकते हैं या लिवर की जांच रिपोर्ट असामान्य हो सकती है। गंभीर लेकिन दुर्लभ मामलों में बहुत कम ब्लड प्रेशर, दिल की धड़कन में रुकावट या एलर्जी हो सकती है। इन्फ्यूजन के दौरान कोई भी नया लक्षण हो तो तुरंत डॉक्टर या नर्स को बताएं।

सुरक्षा सलाह: यह दवा केवल अस्पताल में विशेषज्ञ निगरानी में दी जाती है और इसे घर पर खुद से नहीं लगाया जा सकता। इन्फ्यूजन पंप से धीरे-धीरे दिया जाता है और घोल को रोशनी से बचाकर रखा जाता है। इलाज के दौरान ब्लड प्रेशर और हृदय गति की बार-बार जांच की जाती है। अपनी सभी दवाओं की जानकारी डॉक्टर को दें, खासकर ब्लड प्रेशर की दवाएं, क्योंकि इनके साथ ब्लड प्रेशर बहुत कम हो सकता है। अगर चक्कर आना, बेहोशी, सीने में दर्द, सांस लेने में तकलीफ या नाड़ी बहुत धीमी हो जाए तो तुरंत मेडिकल स्टाफ को बताएं। गर्भावस्था और स्तनपान के बारे में डॉक्टर से सलाह लें।

💡 Did You Know? The first generic medicine was introduced in India in 1970 after the Patents Act was amended.

💊 caldip 10mg infusion Uses & Benefits

[{"condition":"Prevention of cerebral vasospasm after aneurysmal subarachnoid haemorrhage","description":"This medicine is used to reduce the risk of delayed ischaemic neurological deficit caused by narrowing of cerebral arteries after a subarachnoid bleed.","evidence":"Well-established"},{"condition":"Improvement of neurological outcome after subarachnoid haemorrhage","description":"Intravenous nimodipine is used in specialist centres to improve survival and neurological recovery in selected patients after aneurysmal subarachnoid haemorrhage.","evidence":"Established in specialist practice"},{"condition":"Management of established cerebral vasospasm","description":"In some centres this medicine is used as part of a strategy to treat confirmed vasospasm, often alongside other measures such as blood pressure management and endovascular therapy.","evidence":"Limited to specialist settings"}]

Off-label uses: [{"condition":"Prevention of vasospasm after traumatic subarachnoid haemorrhage","description":"Occasionally used in neurocritical care for patients with traumatic subarachnoid bleeding, but evidence is not strong enough to recommend routine use.","evidence":"Limited"},{"condition":"Adjunctive treatment in acute ischaemic stroke","description":"Has been studied in some settings but is not a standard treatment for acute ischaemic stroke.","evidence":"Insufficient"},{"condition":"Refractory migraine or cluster headache in hospital settings","description":"Rarely used in specialist headache centres when other treatments have failed, but this is not an approved indication.","evidence":"Limited"}]

Primary treatment for: Cerebral vasospasm after aneurysmal subarachnoid haemorrhage

Also treats: Delayed cerebral ischaemia, Neurological deficit after subarachnoid haemorrhage, Established cerebral vasospasm in specialist settings

📋 Drug Information

Generic Name(s)Nimodipine
Brand NameCaldip
ManufacturerAlfa Igra Inc
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassCARDIAC
Action ClassCalcium channel blockers- Dihydropyridines (DHP)
Route of AdministrationIntravenous infusion only, administered by a healthcare professional using a controlled infusion pump
StorageStore the infusion solution in its original packaging, protected from light, at room temperature between 15°C and 30°C. Do not freeze. Once prepared for infusion, the solution should be used according to the manufacturer's instructions and hospital policy, and any unused portion should be discarded appropriately.
Shelf LifeThe shelf life of the unopened product is typically 24 to 36 months from the date of manufacture, but the exact expiry date should be checked on the pack. Once the infusion is prepared, it should be used within the time specified by the manufacturer and hospital guidelines.
WHO GuidelineNot established from the available information. Treatment should follow local hospital protocols and specialist neurocritical care guidance.
ICMR GuidelineNot established from the available information. Clinicians should refer to current Indian neurocritical care and neurosurgery guidelines for the management of subarachnoid haemorrhage.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
This medicine must be given only in a monitored hospital setting with continuous blood pressure and heart rate checks.
2
Protect the infusion solution and giving set from light at all times to prevent loss of potency.
3
Use a dedicated intravenous line and a volumetric infusion pump to control the rate precisely.
4
Check blood pressure frequently, especially during the first hours and after any change in infusion rate.
5
Review all concomitant medicines for CYP3A4 interactions before starting the infusion.
6
Monitor liver function in patients with hepatic impairment and adjust the dose accordingly.
7
Watch for early signs of vasospasm, such as new neurological deficits or reduced consciousness.
8
Document the infusion rate, blood pressure, and neurological status regularly in the patient's chart.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
New weakness or numbness after a brain bleed
This medicine is used to prevent or treat cerebral vasospasm, which can cause new neurological deficits.
Likely Use
✅
Severe headache after subarachnoid haemorrhage
This medicine is part of specialist care after a brain bleed, but headache itself needs urgent medical review.
Likely Use
❌
Routine high blood pressure
This medicine is not a routine treatment for high blood pressure.
Not Primary
❌
Fever
This medicine is not a fever reducer.
Not Primary
❌
Migraine attack
This medicine is not a standard treatment for migraine.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionAbsorption is not applicable because this medicine is administered directly into the bloodstream by intravenous infusion. The oral form of nimodipine is absorbed from the gut, but this intravenous product bypasses absorption entirely.
DistributionThis medicine is highly lipophilic and is distributed widely into body tissues, with a large volume of distribution. It crosses the blood-brain barrier and achieves concentrations in brain tissue that are relevant to its clinical effect on cerebral vessels. It is highly bound to plasma proteins.
Protein BindingNimodipine is approximately 95% bound to plasma proteins, mainly albumin.
MetabolismThis medicine is extensively metabolised in the liver, primarily by cytochrome P450 3A4 enzymes, through oxidative pathways including dehydrogenation of the dihydropyridine ring. Its metabolites are largely inactive. Because metabolism depends on CYP3A4, drugs that inhibit or induce this enzyme can significantly change nimodipine levels.
Half-LifeThe elimination half-life of nimodipine is approximately 8 to 9 hours in healthy adults, but it may be longer in patients with hepatic impairment.
ExcretionMetabolites of this medicine are excreted mainly in the urine, with a smaller amount in the faeces. Very little unchanged nimodipine is excreted.
BioavailabilityBioavailability is not applicable for the intravenous route because the medicine is given directly into the bloodstream. For the oral form, bioavailability is low, around 13%, due to first-pass metabolism, but this does not apply to this intravenous product.
Onset of ActionThe effect on blood pressure and cerebral vessels begins within minutes of starting the intravenous infusion, because the medicine reaches the circulation directly.
Peak Plasma TimePeak plasma concentration occurs at the end of the infusion or during a steady-state infusion, since there is no absorption phase for the intravenous route.
Duration of ActionThe clinical effect persists as long as the infusion is running. After the infusion is stopped, the effect gradually wears off over several hours, consistent with the elimination half-life of about 8 to 9 hours.

How It Works

This medicine works by blocking L-type voltage-gated calcium channels in the smooth muscle cells of cerebral arteries. By preventing calcium from entering these cells, it reduces the contraction of the arterial wall and promotes relaxation. Because it is highly lipophilic, it crosses the blood-brain barrier and concentrates in brain tissue, giving it a relatively selective effect on cerebral vessels compared with vessels elsewhere in the body. This helps to counteract the arterial narrowing that occurs after subarachnoid haemorrhage and improves blood flow to at-risk brain regions.

Mechanism Steps

1
Entry into the circulation: This medicine is given directly into the bloodstream as an intravenous infusion, so it does not need to be absorbed from the gut.
2
Crossing into brain tissue: Because it is highly lipophilic, this medicine crosses the blood-brain barrier and reaches cerebral arterial smooth muscle cells.
3
Blockade of calcium channels: It binds to L-type voltage-gated calcium channels and reduces the inward flow of calcium ions into the smooth muscle cell.
4
Reduced smooth muscle contraction: Lower intracellular calcium reduces the activation of contractile proteins, so the arterial wall relaxes.
5
Improved cerebral blood flow: Relaxation of cerebral arteries widens the vessel lumen and improves blood flow to brain regions at risk of ischaemia.

💡 How to Take caldip 10mg infusion

Strength: Nimodipine 10 mg in an intravenous infusion solution, supplied in a ready-to-use or concentrate form as specified by the manufacturer.

1This medicine is given only by a healthcare professional in a hospital or specialist centre.
2The infusion is delivered through a dedicated intravenous line using a volumetric pump.
3The solution and giving set are protected from light during administration.
4Blood pressure and heart rate are monitored frequently, especially when the infusion rate is changed.
5Report any dizziness, fainting, chest pain, difficulty breathing, or unusual bruising to the medical team immediately.
6Do not touch or adjust the infusion pump or tubing yourself.

Dosage Information

Adult DosageThe dose of this medicine is individualised by the treating clinician. In adults, a common regimen after subarachnoid haemorrhage is a continuous intravenous infusion given over several days, with the rate adjusted to maintain stable blood pressure and neurological status. The exact dose, duration, and rate must be determined by a qualified clinician based on the indication, the patient's blood pressure, heart rate, liver and kidney function, and response to treatment. This medicine should never be self-administered.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician or pediatric neurologist for any use in children.
Elderly DosageElderly patients may be more sensitive to the blood pressure-lowering effects of this medicine. The dose should be individualised by the clinician, with close monitoring of blood pressure, heart rate, and neurological status. Lower infusion rates may be needed.
Renal ImpairmentNimodipine is not primarily cleared by the kidneys, so renal impairment is not expected to require a major dose change. However, patients with kidney disease should be monitored for low blood pressure and reduced urine output, and the infusion rate should be adjusted by the clinician as needed.
Hepatic ImpairmentBecause this medicine is extensively metabolised in the liver, patients with hepatic impairment may have higher blood levels and an increased risk of side effects. The dose should be reduced and liver function monitored, as decided by the treating clinician. This medicine is contraindicated in severe hepatic impairment.
Maximum Daily DoseThe maximum daily dose is not a fixed figure and must be determined by the treating clinician based on the patient's condition, blood pressure, and response. This medicine is given as a continuous infusion, and the rate is adjusted to balance effectiveness against the risk of hypotension.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

Grapefruit and grapefruit juice
Avoid
Grapefruit inhibits CYP3A4 and can raise nimodipine levels, increasing the risk of low blood pressure.
St John's wort
Avoid
This herbal product induces CYP3A4 and can reduce the effectiveness of nimodipine.
Alcohol
Avoid
Alcohol can add to blood pressure lowering and increase dizziness and drowsiness.

⏰ What to Do If You Miss a Dose

📌 The infusion is interrupted for a short time
→ The nursing team will assess the patient and decide whether to restart the infusion and at what rate.
💡 Do not attempt to restart or adjust the infusion yourself.
📌 The infusion is stopped for a longer period
→ The treating clinician will review the need for continued treatment and may restart at a lower rate or change the plan.
💡 Any decision must be made by the medical team based on the patient's condition.

⚠️ Side Effects of caldip 10mg infusion

✅ Common Side Effects

Low blood pressure (hypotension) (Common (more than 10%))
The infusion rate may need to be reduced by the medical team. Report dizziness or fainting immediately.
Headache (Common (5-10%))
Tell the nursing staff so that other causes can be excluded and appropriate relief can be given.
Nausea (Common (5-10%))
Inform the medical team. Anti-sickness medicine may be prescribed if needed.
Flushing (Common (5-10%))
This usually settles without treatment. Report if it is severe or associated with breathing difficulty.
Dizziness (Uncommon (1-5%))
Stay lying down until the feeling passes and call for assistance before standing.
Fast heart rate (tachycardia) (Uncommon (1-5%))
The medical team will monitor your heart rate and adjust treatment if necessary.
Swelling of ankles or feet (peripheral oedema) (Uncommon (1-5%))
Report to the medical team. Elevation and dose adjustment may help.

🚨 Serious Side Effects

Severe hypotension (Uncommon (less than 1%))
Seek immediate medical attention. The infusion may need to be stopped or the rate reduced urgently.
Bradycardia or heart block (Rare (less than 0.1%))
Requires immediate medical review and possibly stopping the infusion.
Severe allergic reaction (anaphylaxis) (Rare (less than 0.1%))
Seek emergency help immediately if there is swelling of the face, lips, or throat, or difficulty breathing.
Thrombocytopenia (Rare (less than 0.1%))
Report any unusual bruising or bleeding. Blood tests may be needed.
Clinically significant liver enzyme elevation (Rare (less than 0.1%))
Liver function tests should be checked if symptoms such as yellowing of the eyes or skin appear.

⚠️ Rare Side Effects

Severe skin rash or dermatitis
Stop the infusion and seek medical advice immediately.
Gastrointestinal bleeding
Seek immediate medical attention if there is vomiting of blood or black stools.
Ileus or intestinal obstruction
Report abdominal bloating, pain, or inability to pass stool to the medical team.
Acute kidney injury
Monitor urine output and kidney function tests as advised by the clinician.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Ketoconazole Major
Rifampicin Major
Magnesium sulfate Major
Other antihypertensives Major
Grapefruit juice Moderate
Valproic acid Moderate
Cimetidine Moderate
Beta-blockers Minor
Digoxin Minor
St John's wort Moderate

🚨 Major Interactions

  • Strong CYP3A4 inhibitors (for example ketoconazole, itraconazole, clarithromycin, ritonavir)
  • Strong CYP3A4 inducers (for example rifampicin, carbamazepine, phenytoin, St John's wort)
  • Other antihypertensive medicines and drugs that lower blood pressure
  • Intravenous magnesium sulfate

⚡ Moderate Interactions

  • Grapefruit juice
  • Valproic acid
  • Cimetidine
  • Other calcium channel blockers

🍷 Alcohol Interaction

Alcohol should be avoided during treatment with this medicine because it can add to the blood pressure-lowering effect and increase the risk of dizziness, fainting, and falls. In a hospital setting, alcohol is not permitted, and patients should inform staff about any alcohol use.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known hypersensitivity to nimodipine or any other dihydropyridine calcium channel blocker","Severe hypotension or shock","Severe aortic stenosis or other conditions where a fall in blood pressure is dangerous","Unstable cardiac disease, including recent myocardial infarction or unstable angina","Sick sinus syndrome, sinoatrial block, or second- or third-degree heart block without a pacemaker","Concomitant use with strong CYP3A4 inhibitors such as ketoconazole, itraconazole, clarithromycin, or ritonavir","Severe hepatic impairment","Pregnancy, unless the treating specialist decides the benefit clearly outweighs the risk"]

⚠️ Warnings & Precautions

["This medicine must be given only by a healthcare professional in a setting where blood pressure and heart rate can be monitored continuously.","The infusion must be protected from light and administered through a dedicated line using a volumetric pump.","Blood pressure should be checked frequently, especially during the first hours of treatment and after any change in infusion rate.","Patients with liver disease may need a lower dose because nimodipine is cleared by the liver.","Patients with kidney disease should be monitored for low blood pressure and reduced urine output.","Elderly patients may be more sensitive to the blood pressure-lowering effects.","Avoid grapefruit juice and St John's wort during treatment.","Tell the medical team about all other medicines, especially those that affect blood pressure or are metabolised by CYP3A4.","Do not use this medicine if the solution is cloudy, discoloured, or contains particles.","Do not stop or change the infusion rate without instruction from the treating clinician."]

🤱 Lactation Safety

It is not known whether nimodipine passes into breast milk in amounts that could affect a breastfed baby. Because this medicine is given intravenously in hospital, breastfeeding decisions should be made with the treating team, and alternative feeding may be advised until treatment is completed.

💊 Overdose Management

Overdose with this medicine can cause severe hypotension, bradycardia, and shock. Treatment is supportive and should be carried out in a hospital setting. The infusion should be stopped immediately, and blood pressure and heart rate should be supported with intravenous fluids and, if necessary, vasopressor medicines. There is no specific antidote. Patients should be monitored closely until stable.

⏰ Missed Dose

This medicine is given as a continuous intravenous infusion in hospital, so a missed dose is managed by the nursing and medical team. If the infusion is interrupted, the team will decide whether to restart it and at what rate, based on the patient's condition and the time since the interruption. Patients and families should not attempt to adjust the infusion themselves.

Additional Safety Advice

General Safety

This medicine is given only in a hospital or specialist centre under continuous medical supervision. It must never be self-administered at home. The infusion is delivered through a dedicated line using a volumetric pump, and the giving set and solution must be protected from light. Blood pressure and heart rate are monitored closely, especially during the first hours of treatment. Patients should tell the medical team about all other medicines, especially blood pressure medicines, because the combination can cause a dangerous drop in blood pressure. Anyone who develops severe dizziness, fainting, chest pain, difficulty breathing, or a very slow pulse should alert staff at once. This medicine is not for use in pregnancy unless the treating team decides the benefit clearly outweighs the risk, and breastfeeding should be discussed with the doctor.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more sensitive to the blood pressure-lowering effects of this medicine. They should be monitored closely for hypotension, dizziness, and falls. The dose and infusion rate should be individualised by the clinician, and other medicines that lower blood pressure should be reviewed.

🤰 Pregnancy Planning (TTC)

If you are planning pregnancy or are pregnant, tell your doctor before this medicine is used. The use of this medicine in pregnancy should be decided only by a specialist team after weighing the benefits and risks. Effective contraception should be discussed if appropriate during treatment.

🏥 Post-Surgery Considerations

After neurosurgery, this medicine may be used to prevent vasospasm. The infusion is managed by the surgical and critical care team, with close monitoring of blood pressure, heart rate, and neurological status. Follow all post-operative instructions and report new symptoms immediately.

🦷 Dental Procedures

Tell your dentist about this medicine and your recent hospital treatment before any dental procedure. Blood pressure and heart rate should be stable, and your doctor should be consulted if you have had recent neurological problems. Routine dental care may need to be postponed until you are medically stable.

💚 Lifestyle Tips for Better Results

🏃
Follow your rehabilitation plan, including physical and occupational therapy, as advised by your team.
🥗
Keep your blood pressure well controlled after discharge, as instructed by your doctor.
😴
Avoid smoking and limit alcohol, as these can affect blood vessel health.
💧
Eat a balanced diet rich in fruits, vegetables, and whole grains.
🧘
Stay physically active within the limits recommended by your doctor.
🌞
Get enough sleep and manage stress to support recovery.
🚭
Attend all follow-up appointments and report new symptoms promptly.

🏋️ Exercise Considerations

During the infusion and in the early recovery period after a subarachnoid haemorrhage, strenuous exercise and heavy lifting should be avoided. Follow the advice of your neurosurgeon and rehabilitation team about when it is safe to gradually increase activity. Stop any activity that causes dizziness, chest pain, or severe headache and seek medical advice.

🥗 Diet Recommendations

Eat a balanced diet with plenty of fruits and vegetables.
Choose whole grains and lean proteins.
Limit salt and processed foods to help control blood pressure.
Avoid grapefruit and grapefruit juice during treatment.
Avoid alcohol during treatment.
Stay well hydrated unless your doctor has advised fluid restriction.

💼 Impact on Daily Work & Life

This medicine is given in hospital, so it will affect your work and daily life during treatment. You will need time off work for the infusion and recovery. Driving and operating machinery should be avoided during treatment and until your doctor says it is safe. Plan for support at home during recovery and follow your rehabilitation plan.

🛑 When to Stop This Medicine

This medicine is stopped only by the treating medical team, based on your clinical condition, the risk of vasospasm, and your response to treatment. Do not stop or adjust the infusion yourself. After discharge, if you are on other medicines, do not stop them without speaking to your doctor.

📅 Long-Term Use Effects

Long-term effects of this medicine are mainly related to the underlying condition it is used for, such as subarachnoid haemorrhage. Most patients do not need this infusion for a long period. After discharge, ongoing monitoring may include neurological checks, blood pressure control, and rehabilitation. Liver and kidney function may be reviewed if there were any concerns during treatment. Always discuss any new symptoms with your doctor.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Endovascular therapy for vasospasm

Procedures such as angioplasty or intra-arterial vasodilator therapy may be used in specialist centres for severe vasospasm.

Evidence: Established in specialist practice
Blood pressure management

Careful control of blood pressure is part of standard neurocritical care after subarachnoid haemorrhage.

Evidence: Well-established
Oral nimodipine

In some settings, oral nimodipine may be used instead of or after intravenous treatment, depending on the clinical situation.

Evidence: Established in selected patients

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

There are no specific vaccine interactions established for this medicine. However, after a serious neurological event, vaccination timing should be discussed with your treating doctor. In general, avoid live vaccines during acute hospital treatment unless approved by the specialist.

📦 Storage Guide

✅ DO

Store the product in its original packaging, protected from light, at room temperature between 15°C and 30°C.

❌ DON'T

Do not freeze the product or expose it to direct sunlight.

✅ DO

Use the prepared infusion within the time specified by the manufacturer and hospital policy.

❌ DON'T

Do not use the solution if it is cloudy, discoloured, or contains particles.

✅ DO

Keep the product out of reach of children.

❌ DON'T

Do not transfer the solution to unmarked containers.

✈️ Traveling with This Medicine

This medicine is given only in hospital, so travel advice is mainly relevant after discharge. If you are discharged on other medicines, carry a copy of your prescription and discharge summary. Keep all medicines in their original packaging with the pharmacy label visible. If you are travelling by air, carry medicines in your hand luggage and declare them at security if asked. Store them at room temperature and away from direct sunlight. If you need medical care while travelling, show the emergency card and discharge summary to the treating team. Do not change or stop any medicine without speaking to your doctor.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 52-year-old patient recovering from a subarachnoid haemorrhage in the neurointensive care unit
The patient was started on this medicine as a continuous intravenous infusion to prevent cerebral vasospasm. The nursing team checked blood pressure every hour and adjusted the rate when it dropped slightly. Over the next few days, the patient remained stable and did not develop new neurological deficits. The family was reassured that the infusion was part of standard specialist care.
💡 Lesson: Close monitoring and careful rate adjustment make this medicine safer and more effective in preventing delayed brain injury.
👤 A 60-year-old patient with a history of hypertension who developed low blood pressure during the infusion
This medicine was started after a brain bleed, but the patient's blood pressure fell soon after the infusion began. The medical team reduced the rate, gave intravenous fluids, and continued monitoring. The blood pressure stabilised, and the infusion was continued at a lower rate without further problems.
💡 Lesson: Patients with existing hypertension may be more sensitive to the blood pressure-lowering effect, so the infusion rate must be individualised and monitored closely.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts working within minutes of the infusion beginning, because it is given directly into the bloodstream. Its main benefit is to prevent or reduce narrowing of brain arteries over the following days.

Q: Can I eat or drink normally during the infusion?

A: In most cases you can eat and drink as advised by your medical team, but you should avoid grapefruit juice and alcohol. Follow the instructions given by your nurse or doctor.

Q: Will I need blood tests during treatment?

A: Yes, blood tests may be done to check liver and kidney function, blood counts, and other parameters. The frequency depends on your condition and the treating team's plan.

Q: What should I tell my family about this medicine?

A: Tell them that this is a hospital-only infusion used after a brain bleed to protect the brain. They should inform any new doctor or nurse about this medicine and any allergies.

Q: Can I drive after this treatment?

A: You should not drive during the infusion or immediately after, especially if you have had dizziness or low blood pressure. Ask your doctor when it is safe to drive again.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can this medicine be given at home?
  • How long will I need this infusion?
  • Will this medicine lower my blood pressure too much?
  • Can I take my other medicines during the infusion?
  • What should I do if I feel dizzy during the infusion?
  • Does this medicine affect my liver or kidneys?
  • Can this medicine be used in pregnancy?
  • What happens if the infusion is stopped early?

🔄 Substitutes for caldip 10mg infusion

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine is a general blood pressure medicine.
    Fact: This medicine is a specialist intravenous calcium channel blocker used mainly for cerebral vasospasm after subarachnoid haemorrhage, not for routine hypertension.
  • Myth: This medicine can be taken as a tablet at home.
    Fact: This product is an intravenous infusion and must be given only by a healthcare professional in a monitored setting.
  • Myth: This medicine works immediately and cures the brain bleed.
    Fact: This medicine helps prevent and treat narrowing of brain arteries, but it does not repair the initial bleed and must be part of comprehensive hospital care.
  • Myth: If side effects occur, the patient can stop the infusion.
    Fact: Only the treating medical team should adjust or stop the infusion, because sudden changes can be dangerous.

🔄 Alternative Options

Generic Alternatives

  • Nimodipine intravenous infusion

Brand Alternatives

  • Caldip 10mg infusion

📊 Comparison with Similar Medicines

[{"feature":"Route","this_medicine":"Intravenous infusion","oral_nimodipine":"Oral tablet","note":"The intravenous route allows rapid, controlled delivery in hospital."},{"feature":"Main use","this_medicine":"Prevention and treatment of cerebral vasospasm after subarachnoid haemorrhage","oral_nimodipine":"Similar indication in some settings","note":"The choice depends on the clinical situation and hospital protocol."},{"feature":"Monitoring","this_medicine":"Intensive blood pressure and heart rate monitoring","oral_nimodipine":"Less intensive but still requires monitoring","note":"Intravenous use carries a higher risk of sudden hypotension."}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory